329 related articles for article (PubMed ID: 31301327)
21. Dynorphin, stress, and depression.
Knoll AT; Carlezon WA
Brain Res; 2010 Feb; 1314():56-73. PubMed ID: 19782055
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
[TBL] [Abstract][Full Text] [Related]
23. Recapitulating phenotypes of alcohol dependence via overexpression of Oprk1 in the ventral tegmental area of non-dependent TH::Cre rats.
Lepreux G; Shinn GE; Wei G; Suko A; Concepcion G; Sirohi S; Soon Go B; Bruchas MR; Walker BM
Neuropharmacology; 2023 May; 228():109457. PubMed ID: 36764577
[TBL] [Abstract][Full Text] [Related]
24. Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity.
Tejeda HA; Wu J; Kornspun AR; Pignatelli M; Kashtelyan V; Krashes MJ; Lowell BB; Carlezon WA; Bonci A
Neuron; 2017 Jan; 93(1):147-163. PubMed ID: 28056342
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
Ahmad T; Laviolette SR
Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
[TBL] [Abstract][Full Text] [Related]
26. A midbrain dynorphin circuit promotes threat generalization.
Fellinger L; Jo YS; Hunker AC; Soden ME; Elum J; Juarez B; Zweifel LS
Curr Biol; 2021 Oct; 31(19):4388-4396.e5. PubMed ID: 34388372
[TBL] [Abstract][Full Text] [Related]
27. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
28. Distinct µ-opioid ensembles trigger positive and negative fentanyl reinforcement.
Chaudun F; Python L; Liu Y; Hiver A; Cand J; Kieffer BL; Valjent E; Lüscher C
Nature; 2024 Jun; 630(8015):141-148. PubMed ID: 38778097
[TBL] [Abstract][Full Text] [Related]
29. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
30. Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward.
Al-Hasani R; McCall JG; Shin G; Gomez AM; Schmitz GP; Bernardi JM; Pyo CO; Park SI; Marcinkiewcz CM; Crowley NA; Krashes MJ; Lowell BB; Kash TL; Rogers JA; Bruchas MR
Neuron; 2015 Sep; 87(5):1063-77. PubMed ID: 26335648
[TBL] [Abstract][Full Text] [Related]
31. Food reward-sensitive interaction of ghrelin and opioid receptor pathways in mesolimbic dopamine system.
Kawahara Y; Kaneko F; Yamada M; Kishikawa Y; Kawahara H; Nishi A
Neuropharmacology; 2013 Apr; 67():395-402. PubMed ID: 23220294
[TBL] [Abstract][Full Text] [Related]
32. Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum.
Mitrovic I; Napier TC
Eur J Neurosci; 2002 Jan; 15(2):257-68. PubMed ID: 11849293
[TBL] [Abstract][Full Text] [Related]
33. Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
Liu SS; Pickens S; Burma NE; Ibarra-Lecue I; Yang H; Xue L; Cook C; Hakimian JK; Severino AL; Lueptow L; Komarek K; Taylor AMW; Olmstead MC; Carroll FI; Bass CE; Andrews AM; Walwyn W; Trang T; Evans CJ; Leslie FM; Cahill CM
J Neurosci; 2019 May; 39(21):4162-4178. PubMed ID: 30862664
[TBL] [Abstract][Full Text] [Related]
34. Does the kappa opioid receptor system contribute to pain aversion?
Cahill CM; Taylor AM; Cook C; Ong E; Morón JA; Evans CJ
Front Pharmacol; 2014; 5():253. PubMed ID: 25452729
[TBL] [Abstract][Full Text] [Related]
35. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents.
Ford CP; Beckstead MJ; Williams JT
J Neurophysiol; 2007 Jan; 97(1):883-91. PubMed ID: 17122312
[TBL] [Abstract][Full Text] [Related]
36. Amygdalar κ-opioid receptor-dependent upregulating glutamate transporter 1 mediates depressive-like behaviors of opioid abstinence.
Zan GY; Wang YJ; Li XP; Fang JF; Yao SY; Du JY; Wang Q; Sun X; Liu R; Shao XM; Long JD; Chai JR; Deng YZ; Chen YQ; Li QL; Fang JQ; Liu ZQ; Liu JG
Cell Rep; 2021 Nov; 37(5):109913. PubMed ID: 34731618
[TBL] [Abstract][Full Text] [Related]
37. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell.
Svingos AL; Colago EE; Pickel VM
J Neurosci; 1999 Mar; 19(5):1804-13. PubMed ID: 10024364
[TBL] [Abstract][Full Text] [Related]
38. Effects of pharmacological manipulation of the kappa opioid receptors on the aversive effects of nicotine.
Ward M; Norman H; D'Souza MS
Behav Brain Res; 2018 Feb; 338():56-65. PubMed ID: 29037662
[TBL] [Abstract][Full Text] [Related]
39. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons.
Baimel C; Lau BK; Qiao M; Borgland SL
Cell Rep; 2017 Feb; 18(6):1346-1355. PubMed ID: 28178514
[TBL] [Abstract][Full Text] [Related]
40. Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.
Bazov I; Sarkisyan D; Kononenko O; Watanabe H; Yakovleva T; Hansson AC; Sommer WH; Spanagel R; Bakalkin G
Mol Neurobiol; 2018 Aug; 55(8):7049-7061. PubMed ID: 29383684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
